ALSO NOTED: Invitrogen realigns; Genentech adds more space; Feds study avian flu response;and much more...

> Invitrogen has realigned the company around three new divisions. Release

> Genentech is adding on to the millions of square feet of space it already occupies in South San Francisco. Report

> Federal officials are studying how they would respond to an avian flu pandemic that would infect 92 million Americans in four months. Report

> CombiMatrix Molecular Diagnostics has begun offering influenza testing services that will enable genetic identification of H5N1 bird flu and other types of influenza. Release

> BioTrove has expanded its collaboration with the Schering-Plough Research Institute. Release

And Finally… Industry insiders say a number of political and regulatory barriers are delaying the development of personalized medicines. Report